Albemarle (ALB) Expected to Announce Earnings on Wednesday

Albemarle (NYSE:ALB) will likely be releasing its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to announce earnings of $2.53 per share and revenue of $1.52 billion for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Albemarle (NYSE:ALB) last posted its quarterly earnings data on Wednesday, August 5th. The specialty chemicals company reported $3.75 earnings per share for the quarter, beating the consensus estimate of $3.20 by $0.55. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the previous year, the firm posted $0.11 earnings per share. The business’s revenue was up 31.1% compared to the same quarter last year. On average, analysts expect Albemarle to post $11.19 EPS for the current fiscal year and $11.51 EPS for the next fiscal year.

Albemarle Price Performance

Shares of NYSE:ALB opened at $99.05 on Wednesday. Albemarle has a 52-week low of $88.01 and a 52-week high of $221.00. The stock has a 50 day moving average price of $114.29 and a 200-day moving average price of $150.86.

Albemarle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be given a dividend of $0.41 per share. The ex-dividend date is Friday, December 18th. This represents a $1.64 annualized dividend and a dividend yield of 1.7%.

Analysts Set New Price Targets

Several brokerages recently weighed in on ALB. Barclays initiated coverage on Albemarle in a research note on Monday, October 12th. They issued an “equal weight” rating and a $109.00 price target on the stock. Jefferies Financial Group lowered their price objective on Albemarle from $244.00 to $211.00 and set a “buy” rating for the company in a research report on Tuesday, June 30th. BMO Capital Markets restated an “outperform” rating and set a $175.00 target price on shares of Albemarle in a report on Tuesday, October 6th. Wall Street Zen raised shares of Albemarle from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Finally, UBS Group reduced their target price on shares of Albemarle from $175.00 to $150.00 and set a “buy” rating on the stock in a research report on Monday, October 5th. Fifteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $179.41.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.